Understanding how certain viral proteins affect the immune response to COVID-19
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
This study is looking at how certain viral proteins help the COVID-19 virus avoid detection by our immune system, with the hope that understanding this could lead to better treatments and vaccines for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Loyola University Chicago NIH-funded |
| Lab location | 1 site (Maywood, United States) |
| Project ID | NIH-11140690 on NIH RePORTER |
What this research studies
This research investigates how viral interferon antagonists influence the immune response during SARS-CoV-2 infection. By studying the interactions between coronaviruses and the host's immune system, the research aims to uncover mechanisms that allow the virus to evade immune detection. The approach involves examining specific viral proteins that may delay the activation of immune responses, which could lead to more effective treatments or preventive measures against COVID-19. Patients may benefit from insights gained that could inform future therapies or vaccines.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with SARS-CoV-2 or are at high risk of infection.
Not a fit: Patients who are not infected with SARS-CoV-2 or those who have already recovered from COVID-19 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for treating or preventing COVID-19 by enhancing the immune response.
How similar studies have performed: Other research has shown promise in understanding viral mechanisms of immune evasion, suggesting that this approach could yield valuable insights.
Where this research is happening
Maywood, United States
- Loyola University Chicago — Maywood, United States (Active)
Researchers
- Principal investigator: Baker, Susan C. — Loyola University Chicago
- Study coordinator: Baker, Susan C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.